Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q3	-- / 13.402B	--
--	2025/Q2	-- / 13.936B	--
Apr 29, 2025	2025/Q1	13.233B / 13.050B	--
Jan 31, 2025	2024/Q4	13.153B / 12.823B	--
Oct 29, 2024	2024/Q3	12.823B / 12.666B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q3-- / 13.402B--

--2025/Q2-- / 13.936B--

Apr 29, 20252025/Q113.233B / 13.050B--

Jan 31, 20252024/Q413.153B / 12.823B--

Oct 29, 20242024/Q312.823B / 12.666B--

Unlock Free Earnings Estimates

Open Account

6-K: RFinancial Report Q1 2025

Apr 29 06:04 ET

6-K: Report of foreign private issuer (related to financial reporting)

Jan 31 07:16 ET

20-F: FY2024 Annual Report

Jan 31 07:11 ET

6-K: Novartis Upgrades Mid-Term Guidance

Nov 25, 2024 10:22 ET

NVS Novartis AG

Novartis AG Key Stats